View time: 2:40 mins
We interview Vera Hillewaert, Scientist at Janssen Research & Development, LLC (NJ, USA), to discuss her research and the impact of rules and regulations.
View time: 2:40 mins
Read time: 1 min
Citoxlab Group (Évreux, France) has announced it will acquire Solvo Biotechnology (Budaörs, Hungary) securing its position as a leader among the top five non-clinical CROs.
Read time: 2 mins
In this conference report, the authors reivew the 5th China Bioanalysis Forum (CBF) Annual conference, which was held in Beijing Century Lotus Hotel (China) during 16–18 June 2017.
Charles River (MA, USA) to expand global position with the procurement of global CRO, MPI Research (MI, USA).
LC-MS-based approaches are increasingly used for the quantification of proteins in biological samples. Traditionally, triple…
Improved efficiency in neonatal diagnostics promised with the launch of a new device from PerkinElmer Inc (MA, USA).
Wacker Biotech GmbH (Jena, Germany) have announced that they will manufacture the active ingredient in the drug Retavase®. This drug has obtained FDA approval to treat acute myocardial infarction in adults.
Who are the people behind the science? We interviewed key experts to uncover who their bioanalytical hero is. In this series we sit down with Chad Briscoe (PRA Health Sciences), Joy Concepcion (Gyros Protein Technologies), Caitlin Dunning (Waters Corporation), Mike Godeny (Merck KGaA), Sankeetha Nadarajah (Bioanalysis), Steve Piccoli (WRIB), Nikunj Tanna (Waters Corporation) and Amanda Wilson (Astrazeneca).
Implementing a tiered approach to bioanalytical method validation for large-molecule ligand-binding assay methods in pharmacokinetic assessments
Bioanalytical methods must enable the delivery of data that meet sound, scientifically justified, fit-for-purpose criteria. This perspective piece highlights three tiers of method validation – regulatory, scientific and research validations. The criteria for selecting the appropriate application of each of these PK method validation workflows are discussed.
MSD Research Laboratories (NJ, USA) announces the establishment of a new life sciences discovery research facility, which will be based in London.